Propofol inhibits proliferation and metastasis by up-regulation of miR-495 in JEG-3 choriocarcinoma cells

References

• Kurman RJ, Carcangiu ML, Herrington CS. WHO classification of tumours of female reproductive organs. Lyon: International Agency for Research on Cancer (IARC); 2014.
   Google Scholar
• Hertz R, Mc LI, Spencer DB. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med. 1956;93:361.
   PubMed Web of Science ®Google Scholar
• Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203:531–539.
   PubMed Web of Science ®Google Scholar
• Chao A, Tsai CL, Wei PC, et al. Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma. Cancer Lett. 2010;291:99–107.
   PubMed Web of Science ®Google Scholar
• Iem S. Gestational trophoblastic neoplasia–pathogenesis and potential therapeutic targets. Lancet Oncol. 2007;8:642.
   PubMed Web of Science ®Google Scholar
• Bartel D. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 2005;302:1–12.
   Google Scholar
• Mao Y, Li L, Liu J, et al. MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1. Oncotarget. 2016;7:51223–51236.
   PubMedGoogle Scholar
• Hee LS, Dong JY, Sun CY, et al. Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells. Oncotarget. 2015;6:33269–33278.
   PubMedGoogle Scholar
• Hwang-Verslues WW, Chang P-H, Wei P-C, et al. miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1. Oncogene. 2011;30:2463.
   PubMed Web of Science ®Google Scholar
• Cao M, Nie W, Li J, et al. MicroRNA-495 induces breast cancer cell migration by targeting JAM-A. Protein Cell. 2014;5:862–872.
   PubMed Web of Science ®Google Scholar
• Xu YY, Jing T, Quan H, et al. MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer. Tumor Biol. 2016;37:239–251.
   PubMedGoogle Scholar
• Li Z, Cao Y, Jie Z, et al. miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Lett. 2012;323:41–47.
   PubMed Web of Science ®Google Scholar
• Miyata T, Kodama T, Honma R, et al. Influence of general anesthesia with isoflurane following propofol-induction on natural killer cell cytotoxic activities of peripheral blood lymphocytes in dogs. J Veter Med Sci. 2013;75:917.
   PubMed Web of Science ®Google Scholar
• Altenburg JD, Harvey KA, Mccray S, et al. A novel 2,6-diisopropylphenyl-docosahexaenoamide conjugate induces apoptosis in T cell acute lymphoblastic leukemia cell lines. Biochem Biophys Res Commun. 2011;411:427–432.
   PubMed Web of Science ®Google Scholar
• Mammoto T, Mukai M, Mammoto A, et al. Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett. 2002;184:165.
   PubMed Web of Science ®Google Scholar
• Ye Z, Jingzhong L, Yangbo L, et al. Propofol inhibits proliferation and invasion of osteosarcoma cells by regulation of microRNA-143 expression. Oncol Res. 2013;21:201–207.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wu GQ, Zhang Y, et al. Propofol induces apoptosis of hepatocellular carcinoma cells by upregulation of microRNA-199a expression. Cell Biol Int. 2013;37:227–232.
   PubMed Web of Science ®Google Scholar
• Inada T, Kubo K, Shingu K. Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol. J Anesth. 2011;25:569–575.
   PubMed Web of Science ®Google Scholar
• Huang Z, Li S, Fan W, et al. Transforming growth factor β1 promotes invasion of human JEG-3 trophoblast cells via TGF-β/Smad3 signaling pathway. Oncotarget. 2017;8:33560–33570.
   PubMedGoogle Scholar
• Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14:818–829.
   PubMed Web of Science ®Google Scholar
• Li JZ, Wang ZL, Xu WH, et al. MicroRNA-495 regulates migration and invasion in prostate cancer cells via targeting Akt and mTOR signaling. Cancer Invest. 2016;34:181–188.
   PubMed Web of Science ®Google Scholar
• Yan L, Yao J, Qiu J. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D. Biomed Pharmacother. 2017;96:974–981.
   PubMed Web of Science ®Google Scholar
• Meng J, Chen S, Han JX, et al. Twist1 regulates vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma. Cancer Res. 2018;78:4150–4162.
   PubMed Web of Science ®Google Scholar
• D'Arpino MC, Fuchs AG, Sanchez SS, et al. Extracellular matrix remodeling and TGF-beta1/Smad signaling in diabetic colon mucosa. Cell Biol Int. 2018;42:443–456.
   PubMed Web of Science ®Google Scholar
• Zhang J, Shan WF, Jin TT, et al. Propofol exerts anti-hepatocellular carcinoma by microvesicle-mediated transfer of miR-142-3p from macrophage to cancer cells. J Transl Med. 2014;12:1–9.
   PubMed Web of Science ®Google Scholar
• Cui WY, Liu Y, Zhu YQ, et al. Propofol induces endoplasmic reticulum (ER) stress and apoptosis in lung cancer cell H460. Tumour Biol. 2014;35:5213–5217.
   PubMedGoogle Scholar
• Z S, XK H, QP W. Propofol induces apoptosis of epithelial ovarian cancer cells by upregulation of microRNA let-7i expression. Eur J Gynaecol Oncol. 2014;35:688.
   PubMed Web of Science ®Google Scholar
• Wang P, Chen J, Mu LH, et al. Propofol inhibits invasion and enhances paclitaxel- induced apoptosis in ovarian cancer cells through the suppression of the transcription factor slug. Eur Rev Med Pharmacol Sci. 2013;17:1722–1729.
   PubMed Web of Science ®Google Scholar
• Xu YB, Du QH, Zhang MY, et al. Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells. Eur Rev Med Pharmacol Sci 2013;17:2486.
   PubMed Web of Science ®Google Scholar
• Wu KC, Yang ST, Hsia TC, et al. Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. Anticancer Res. 2012;32:4833–4842.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang D, Wu G-Q, et al. Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression. Hepatobiliary Pancreat Dis Int. 2013;12:305–309.
   PubMed Web of Science ®Google Scholar
• Wang ZT, Gong HY, Zheng F, et al. Propofol suppresses proliferation and invasion of gastric cancer cells via downregulation of microRNA-221 expression. Genet Mol Res. 2015;14:8117.
   PubMed Web of Science ®Google Scholar
• Wei T, Zhu W, Fang S, et al. miR-495 promotes the chemoresistance of SCLC through the epithelial-mesenchymal transition via Etk/BMX. Am J Cancer Res. 2017;7:628.
   PubMed Web of Science ®Google Scholar
• Martin FT, Dwyer RM, Kelly J, et al. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat. 2010;124:317–326.
   PubMed Web of Science ®Google Scholar
• D'Angelo RC, Liu XW, Najy AJ, et al. TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells. Mol Cancer Res. 2014;12:1324–1333.
   PubMed Web of Science ®Google Scholar
• Zhang P, Sun Y, Ma L. ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle. 2015;14:481–487.
   PubMed Web of Science ®Google Scholar
• Casas E, Kim J, Bendesky A, et al. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res. 2011;1;71:245–254.
   PubMed Web of Science ®Google Scholar
• Qiang L, Zhao B, Ming M, et al. Regulation of cell proliferation and migration by p62 through stabilization of Twist1. Proc Natl Acad Sci USA. 2014;111:9241–9246.
   PubMed Web of Science ®Google Scholar
• Yu JR, Tai Y, Jin Y, et al. TGF-β/Smad signaling through DOCK4 facilitates lung adenocarcinoma metastasis. Genes Dev. 2015;29:250–261.
   PubMed Web of Science ®Google Scholar
• Heldin C-H, Landström M, Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol. 2009;21:166–176.
   PubMed Web of Science ®Google Scholar